Guinea
Tuberculosis profile
| High HIV burden |
Population  2012 11 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 2.6 (1.1–4.8) 23 (9.8–42)
Mortality (HIV+TB only) 1.2 (1–1.4) 10 (8.7–12)
Prevalence  (includes HIV+TB) 31 (16–53) 274 (136–459)
Incidence  (includes HIV+TB) 20 (17–24) 178 (146–213)
Incidence (HIV+TB only) 3.7 (3–4.4) 32 (27–39)
Case detection, all forms (%) 56 (47–68)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 6 653 (61) Relapse 489 (68)
Smear-negative 1 510 (14) Treatment after failure 127 (18)
Smear-unknown / not done 0 (0) Treatment after default 107 (15)
Extrapulmonary 2 434 (22) Other 0 (0)
Other 321 (3)      
Total new 10 918   Total retreatment 723  
           
Other (history unknown) 0        
Total new and relapse 11 407   Total cases notified 11 641  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 2.1    
Age < 15 77    
Laboratories 2012
Smear (per 100 000 population) 0.5
Culture (per 5 million population) 0.4
Drug susceptibility testing (per 5 million population) 0.4
Is second-line drug susceptibility testing available? No
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 82   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 86  
Retreatment 64  
TB/HIV 2012 Number (%)
TB patients with known HIV status 7 575 (65)
HIV-positive TB patients 1 859 (25)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 1 544 (83)
HIV-positive TB patients on antiretroviral therapy (ART) 903 (49)
HIV-positive people screened for TB 832  
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 0.56 (0.11–1.6) 28 (14–47)
MDR-TB cases among notified pulmonary
TB cases
47 (10–140) 200 (100–340)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB      
Laboratory-confirmed MDR-TB cases     69
Patients started on MDR-TB treatment     15
Financing TB control 2013
National TB programme budget (US$ millions)  
% Funded domestically  
% Funded internationally  
% Unfunded  
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-18 Data: www.who.int/tb/data